Nuclein, a leader in rapid, point-of-care molecular diagnostics, today announced it has received U.S. Food and Drug ...

Before the self-test, the only other way women could determine if they contracted the STI was with a lab or PCR test, which is often costly and invasive for the patient. The at-home test ...

SOUTHLAKE, Texas, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Trinity Investors, a leading alternative asset management firm, proudly announces a significant milestone achieved by portfolio company Nuclein, LLC ...